ARCHIVES

Techniclone Wins Patent For Tumor Necrosis Therapy.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

January 24, 2014

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

The Avastin Story In A Nutshell: A Timeline

May 27, 2011

Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors.

June 10, 2005